Swiss National Bank - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 2 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,536,662
+5.6%
123,800
+2.4%
0.00%0.0%
Q2 2023$2,402,283
+10.1%
120,900
-5.1%
0.00%
+100.0%
Q1 2023$2,182,362
-15.5%
127,400
-3.5%
0.00%
-50.0%
Q4 2022$2,583,240
+59.5%
132,000
+30.0%
0.00%
+100.0%
Q3 2022$1,620,000
+19.3%
101,500
+2.8%
0.00%0.0%
Q2 2022$1,358,000
-6.3%
98,700
+8.0%
0.00%0.0%
Q1 2022$1,450,000
-21.0%
91,400
+8.7%
0.00%0.0%
Q4 2021$1,836,000
-27.0%
84,1000.0%0.00%
-50.0%
Q3 2021$2,514,000
-29.1%
84,100
+5.0%
0.00%0.0%
Q2 2021$3,548,000
+15.2%
80,100
+15.4%
0.00%0.0%
Q1 2021$3,079,000
-18.4%
69,400
+0.9%
0.00%
-33.3%
Q4 2020$3,773,000
+139.9%
68,8000.0%0.00%
+200.0%
Q3 2020$1,573,000
+11.9%
68,800
+2.4%
0.00%0.0%
Q2 2020$1,406,000
+58.7%
67,200
+5.8%
0.00%0.0%
Q1 2020$886,000
-37.8%
63,500
+1.4%
0.00%0.0%
Q4 2019$1,425,000
+115.6%
62,600
+10.4%
0.00%0.0%
Q3 2019$661,000
-19.6%
56,700
+3.5%
0.00%0.0%
Q2 2019$822,000
+5.2%
54,800
+23.1%
0.00%0.0%
Q1 2019$781,000
+39.7%
44,500
+18.0%
0.00%0.0%
Q4 2018$559,000
-39.8%
37,7000.0%0.00%0.0%
Q3 2018$928,000
+25.4%
37,7000.0%0.00%0.0%
Q2 2018$740,00037,7000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders